InfoVizor
Guides and updates that help you understand cancer care without the jargon.
More topics (31)
Biomarkers & Genetic Testing: How Results Guide Cancer Treatment
A clear explanation of cancer biomarkers and genetic testing—what tests are done, why they’re ordered, what results mean, and how they influence modern treatment decisions.
Cancer Biomarkers by Cancer Type
A cancer-by-cancer overview of commonly tested biomarkers, what they’re used for, and when they influence treatment decisions.
Bladder Cancer Treatments: Muscle-Invasive vs Non–Muscle-Invasive and What Changes Options
A practical guide to bladder cancer care—why depth of invasion matters, typical treatment pathways, and how immunotherapy and targeted approaches fit in advanced disease.
Endometrial (Uterine) Cancer Treatments: Stage, Risk Features, and Modern Systemic Options
A clear guide to endometrial cancer care—how stage and pathology risk features guide surgery, radiation, and systemic therapy, and why molecular testing is increasingly important.
Ovarian Cancer Treatments: Surgery, Chemotherapy, and Why Tumor Biology Matters
A serious, plain-language guide to ovarian cancer care—subtypes, staging, surgery plus chemotherapy, maintenance therapy concepts, and what changes options over time.
Prostate Cancer Treatments: How Decisions Are Made Across Stages
A clear guide to prostate cancer care—risk groups, hormone therapy (ADT), modern systemic options, radiopharmaceuticals, and what comes next if treatments stop working.
Blood Cancers: Leukemia, Lymphoma, and Myeloma (How Treatment Decisions Are Made)
A clear guide to blood cancers—what they are, how doctors classify them, and the modern treatment tools including targeted therapy, immunotherapy, CAR-T, and bispecific antibodies.
Brain Tumors: Gliomas and Glioblastoma (How Modern Treatment Decisions Are Made)
A clear guide to brain tumor care—why molecular testing matters, what typical treatment includes, and how goals and options differ across glioma subtypes.
Breast Cancer Treatments: Subtypes, Biomarkers, and What Comes Next
A detailed guide to breast cancer care—HR+/HER2-, HER2+, and triple-negative—how treatment is chosen, and what’s changing with newer therapies like antibody–drug conjugates.
Pancreatic Cancer Treatments: What’s Standard Today and What’s Emerging
A serious, plain-language guide to pancreatic cancer care—how stage drives options, why chemotherapy is central, and which biomarkers can open additional approaches.
Radiology Reports: How to Understand Your Scans (Without the Panic)
Every scan comes with a radiology report—but they’re written for clinicians, not patients. Learn what common terms mean, what they don’t mean, and how VisitVizor helps translate imaging into plain English.
Colorectal Cancer Treatments: The Role of Stage, Biomarkers, and Immunotherapy
A practical guide to colorectal cancer care—what changes treatment decisions, how biomarkers like MSI/MMR matter, and what options are used across stages.
Lung Cancer Treatments: How Decisions Are Made (NSCLC vs SCLC)
A clear, detailed guide to modern lung cancer care—subtypes, biomarkers, first-line options, and what changes when treatments stop working.
Cancer Treatments Overview: What Patients Can Expect
A patient-friendly overview of common cancer treatment types, how care teams choose plans, and what to ask your oncologist.
Emerging cancer therapies: CAR-T, PROTACs, and next-generation targeting
A 2025 review explores a wide range of emerging cancer therapies, highlighting immune-based, gene-driven, metabolic, and protein-targeting strategies that aim to improve precision and overcome treatment resistance.